Allspring Global Investments Holdings, LLC Arcus Biosciences, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $59.3 Billion
- Q4 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 11,952 shares of RCUS stock, worth $149,997. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,952
Previous 11,924
0.23%
Holding current value
$149,997
Previous $182,000
2.75%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RCUS
# of Institutions
196Shares Held
51.6MCall Options Held
236KPut Options Held
141K-
Black Rock Inc. New York, NY9.76MShares$123 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.47MShares$68.6 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.48MShares$43.7 Million0.48% of portfolio
-
State Street Corp Boston, MA3.01MShares$37.8 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.44MShares$30.6 Million0.1% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $906M
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...